Catalyst Pharmaceuticals (CPRX) Stock: Gaining Big On Financial Results

Catalyst Pharmaceuticals CPRX Stock News

Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) is having an incredibly strong start to the trading session this mroning, and for good reason. The company reported its financial results, beating expectations on all accounts. Today, we’ll talk about: The financial results; what we’re seeing from CPRX stock as a result; and what we’ll be watching for ahead. … Read more

Catalyst Pharmaceuticals (CPRX) Stock: Gaining On Data Publication

Catalyst Pharmaceuticals CPRX Stock News

Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) is headed up in the market this morning, and for good reason. The company announced that data from its Phase 3 clinical trial was published in the Journal of Clinical Neuromuscular Disease.  As you could imagine, the news proved to excite investors, sending the stock on a run for the … Read more

Catalyst Pharmaceuticals (CPRX) Stock: Is Now The Time To Dive In?

Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) is a stock that is grabbing the attention of the masses when it comes to biotechnology investors, and for good reason. The company not only has a pretty impressive pipeline, one treatment in the pipeline is the subject of a New Drug Application with the FDA that was just announced today. … Read more

Catalyst Pharmaceuticals (CPRX) Stock: Gaining Big On Clinical Data

Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced data from a key Phase 3 clinical trial. Of course, that data was positive, leading to excitement among investors and sending the stock screaming for the top. Today, we’ll talk about … Read more

Catalyst Pharmaceuticals (CPRX) Stock: Gaining Big On Firdapse® Update

Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) is having an overwhelmingly positive start to the trading session this morning after providing investors with an update on the status of the Firdapse®. Of course, the update was positive, leading to excitement among investors and causing gains in the value of the stock. Currently (9:58), CPRX is trading at … Read more

Catalyst Pharmaceuticals (CPRX) Stock: Continues Gaining On Biocept (BIOC) Deal

Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) Catalyst Pharmaceuticals is having an incredibly strong day in the market today, following up on gains that we’ve seen on the stock since yesterday. The stock started the day slightly in the green, and throughout the day, has continued upward. Below, we’ll talk about what we’re seeing from CPRX, why, … Read more

Catalyst Pharmaceuticals (CPRX) Stock: Can Piper Jaffray Fueled Gains Continue?

Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) Catalyst Pharmaceuticals is having an incredible day in the market today, and for good reason. Piper Jaffray, one of the most trusted analysts weighing in on market activity, weighed in on the stock. Judging by the reaction in the market, it’s obvious that the opinion was overwhelmingly positive. Today, we’ll … Read more

Biggest Gainers In Biotech Tech Today | Synergy Pharmaceuticals (SGYP) | Catalyst Pharmaceutical Partners (CPRX) | Rockwell Medical (RMTI) | Vanda Pharmaceuticals (VNDA) | Nektar Therapeutics (NKTR)

Today hasn’t been the best day for US stocks; especially in the biotech space. Unfortunately, when looking at the biotech sector, we’re seeing a sea of red. However, there are a few stocks that are doing well regardless of today’s conditions in the market. Here are some of the biggest gainers in biotech today and … Read more

C.N.A. Stocks Today | MannKind Corporation (MNKD) | Synergy Pharmaceuticals (SGYP) | Catalyst Pharmaceutical Partners (CPRX)

When I created CNA Finance, I decided that I would talk about upcoming catalysts, notable movements, and alpha opportunities in the market…that’s where CNA came from. So, I thought it would be a good idea to write a post every day that points out an upcoming catalyst, a stock with notable movements, and an alpha … Read more